SEC Form 4 · accession 0000904454-18-000628
Verastem, Inc. · VSTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
NgocDiep T. Le M.D. Ph.D.
Officer — Chief Medical Officer
Period of report
Sep 24, 2018
Accepted (ET)
Oct 2, 2018 · 6:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001526119
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.97 | Sep 24, 2018 | A | 5,000 | A | Sep 24, 2018 | Jan 5, 2028 | Common Stock | 5,000 | 5,000 | D |
| Stock Option (Right to Buy)F2 | $4.63 | Sep 24, 2018 | A | 70,000 | A | Sep 24, 2018 | Oct 9, 2027 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F1On January 5, 2018, the Reporting Person was granted an option to purchase 12,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 2,500 shares. 40% of the performance criteria was met on September 24, 2018, resulting in vesting of the option as to 5,000 shares.
- F2On October 9, 2017, the Reporting Person was granted an option to purchase 70,000 shares of common stock, to vest in full upon the Issuer's satisfaction of certain performance milestones. Such performance criteria were met on September 24, 2018, resulting in the vesting of the option.